Bridging clinical insight and laboratory model in high-grade serous ovarian carcinoma (HGSOC) using DNA sequencing-based profiling of TP53 (IMAGE)
Caption
Figure 1: Hemocytometer dead cells count.
Here is the bar graph showing the hemocytometer based dead cell counts for each treatment group across day 1, day 2 and day 4 (24 hours post treatment). The data clearly indicated that dead cells increased in combo with high concentration drug group. The C and L presents clinical and laboratory samples respectively and each group has separate control.
Credit
Copyright: © 2025 Iqbal. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Usage Restrictions
With credit to the original source.
License
Original content